News & Perspective

Dec 13, 2011

Dec 13, 2011

Novartis says cell-based flu vaccine facility ready to produce

(CIDRAP News) – Novartis's new cell-culture based influenza vaccine factory in North Carolina has begun making a prepandemic H5N1 flu vaccine and is ready to start producing vaccines for a real pandemic when needed, the company and federal health officials announced yesterday.

The facility in Holly Springs, N.C., billed as the first of its kind in the United States, was dedicated yesterday after a long testing process.

Oct 06, 2011

Oct 06, 2011

Study finds H1N1 pandemic in Mexico more deadly

(CIDRAP News) – Researchers who took a detailed look at 2009 H1N1 deaths in Mexico, where the virus was first detected, found that the new flu virus was more deadly than most seasonal flu epidemics and more lethal than in other countries, which confirms impressions early in the pandemic that the disease was worse in Mexico.

Aug 18, 2011

Aug 18, 2011

NEWS SCAN: 2009 H1N1 virus reassortant, H7N7 as potential pandemic virus, rising legionellosis cases, cholera in Cameroon

Swine reassortant suggests 2009 H1N1 virus could cause more troubleScientists have found a hybrid influenza virus in swine that combines elements of the pandemic 2009 H1N1 virus and a Eurasian swine flu virus, suggesting that continued circulation of the pandemic virus in pigs could lead to novel viruses with the ability to infect humans, according to a report published yesterday in the Journal of Virology. The detection of the pandemic virus in pigs prompted a flu

Aug 15, 2011

Aug 15, 2011

Study supports overall effectiveness of 2009 H1N1 vaccine

(CIDRAP News) – A large, multi-center study of how well the 2009 H1N1 vaccines performed in the United States during the pandemic found that it offered significant protection, especially in older children and nonelderly adults, and had the ability to cut the number of flu-related doctor visits by at least half.

Jul 14, 2011

Jul 14, 2011

Journal offers insights on flu pandemics back to 1889

(CIDRAP News) – A special supplement published by Vaccine offers some new insights about historical influenza pandemics, including how different age-groups were affected in the 1889 pandemic and how the unusual age distribution of cases in the disastrous pandemic of 1918-20 changed in the ensuing years.

Jul 13, 2011

Jul 13, 2011

Study: Adjuvanted H1N1 vaccines had little effect on GBS risk

(CIDRAP News) – A five-country study from Europe indicates that the use of adjuvanted vaccines against the pandemic H1N1 influenza virus probably did not increase the risk of Guillain-Barre syndrome (GBS), but the investigators could not firmly rule out a slightly greater chance of suffering the paralytic condition.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»